| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.500 | None | 0.968 | 3 | 1 | 1995 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.500 | None | 1.000 | 3 | 1 | 2008 | 2018 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.200 | None | 0.953 | 1 | 1 | 2004 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.885 | 1 | 1 | 1993 | 2019 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.160 | None | 1.000 | 1 | 2 | 1997 | 2016 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
disease | 0.110 | None | 1.000 | 2 | 2 | 2009 | 2016 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.150 | None | 1.000 | 2 | 4 | 2003 | 2017 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.200 | None | 0.889 | 3 | 2 | 1998 | 2019 | ||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
disease | 0.170 | None | 0.875 | 1 | 1 | 1998 | 2017 | ||||||||
|
TNF receptor superfamily member 1A | 0.409 | 0.923 | 0.99 |
|
disease | 0.140 | None | 1.000 | 1 | 1 | 2008 | 2018 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 2010 | 2018 | ||||||||
|
SMAD family member 3 | 0.415 | 0.923 | 0.80 |
|
disease | 0.130 | None | 1.000 | 4 | 3 | 2011 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.120 | None | 0.750 | 2 | 1 | 1997 | 2017 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 0.700 | None | 0.909 | 1 | 3 | 1998 | 2019 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protein tyrosine phosphatase receptor type C | 0.435 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
serine/threonine kinase 11 | 0.435 | 0.808 | 0.99 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
CD28 molecule | 0.436 | 0.885 | 0.36 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 2013 | 2017 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.180 | None | 0.889 | 1 | 1 | 2010 | 2018 | ||||||||
|
ETS proto-oncogene 1, transcription factor | 0.444 | 0.731 | 0.78 |
|
disease | 0.120 | None | 1.000 | 1 | 2 | 2015 | 2016 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2016 | 2019 | ||||||||
|
bromodomain containing 2 | 0.450 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protein kinase C beta | 0.453 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2015 | 2017 | ||||||||
|
interleukin 27 | 0.457 | 0.808 | 0.78 |
|
disease | 0.170 | None | 1.000 | 2 | 1 | 2009 | 2017 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2015 | 2015 |